The KSR1 protein contains five conserved areas (CA). The CA1 region is unique to KSR1 protein; the CA2 region is a proline-rich region; the CA3 region is implicated in the Ras-induced plasma membrane localization; the CA4 region is a serine/threonine rich region and contains the MAPK docking site (FXFP); and the putative kinase domain (CA5), which contains an amino acid variation in subdomain II that suggests that this protein is catalytically inert. The KSR1 protein is composed of 921 amino acids.
Mutations

Note
There have been no prominent germinal or somatic mutations identified.
Implicated in
Cancer Note KSR1 has not been found to be upregulated or downregulated in tumors. However, studies in KSR1 knockout mice showed that the mice were less susceptible to papilloma virus driven tumors, indicating that KSR1 is required for Ras-mediated oncogenesis.
To be noted
Note KSR1 is primarily recognized as a scaffold for the Raf/MEK/ERK kinase cascade. However, there are several published studies that sustain that KSR1 has catalytic activity. KSR1 is recognized as a pseudokinase, since mammalian KSR1 does not possess the lysine responsible for ATP orientation and hydrolysis in the putative kinase domain. This lysine is present in C. elegans and D. melanogaster, but mutation of this site did not affect activation of the Raf/MEK/ERK pathway. A recent publication (Rajakulendran et al., 2009) showed that KSR1 dimerization via its kinase domain to Raf facilitated the activation of Raf without KSR1 catalytic activity. It remains possible that KSR1 proteins have catalytic activity based on a yet to be identified novel mechanism.
